Radiation Therapy Plus Carboplatin and Lobradimil in Treating Children With Newly Diagnosed Brain Stem Gliomas

ClinicalTrials.gov ID: NCT00005602

Public ClinicalTrials.gov record NCT00005602. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 21, 2026, 12:37 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase I Study of Concurrent Cereport and Carboplatin With Radiation Therapy for Children With Newly-Diagnosed Brain Stem Gliomas

Study identification

NCT ID: NCT00005602
Recruitment status: Completed
Study type: Interventional
Phase: Phase 1
Lead sponsor: Children's Oncology Group; Network
Enrollment: 13 participants

Conditions and interventions

Conditions

Brain and Central Nervous System Tumors

Interventions

carboplatin Drug
cereport Drug
radiation therapy Radiation

Drug · Radiation

Eligibility (public fields only)

Age range: 3 Years to 21 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jan 31, 2001
Primary completion: Dec 31, 2004
Completion: Aug 31, 2005
Last update posted: Feb 20, 2014

2001 – 2005

United States locations

U.S. sites: 19
U.S. states: 13
U.S. cities: 18

Facility	City	State	ZIP	Site status
Children's Hospital Los Angeles	Los Angeles	California	90027-0700	—
Lucile Packard Children's Hospital at Stanford	Palo Alto	California	94304	—
UCSF Comprehensive Cancer Center	San Francisco	California	94143-0128	—
Children's National Medical Center	Washington D.C.	District of Columbia	20010-2970	—
Indiana University Cancer Center	Indianapolis	Indiana	46202-5289	—
MBCCOP - LSU Health Sciences Center	New Orleans	Louisiana	70112	—
Dana-Farber Cancer Institute	Boston	Massachusetts	02115	—
Mayo Clinic Cancer Center	Rochester	Minnesota	55905	—
University of Mississippi Medical Center	Jackson	Mississippi	39216-4505	—
Herbert Irving Comprehensive Cancer Center	New York	New York	10032	—
State University of New York - Upstate Medical University	Syracuse	New York	13210	—
Albert Einstein Clinical Cancer Center	The Bronx	New York	10461	—
Children's Hospital Medical Center - Cincinnati	Cincinnati	Ohio	45229-3039	—
Doernbecher Children's Hospital	Portland	Oregon	97201-3098	—
Children's Hospital of Philadelphia	Philadelphia	Pennsylvania	19104	—
Children's Hospital of Pittsburgh	Pittsburgh	Pennsylvania	15213	—
University of Texas - MD Anderson Cancer Center	Houston	Texas	77030-4009	—
Baylor College of Medicine	Houston	Texas	77030	—
Children's Hospital and Regional Medical Center - Seattle	Seattle	Washington	98105	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00005602, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Feb 20, 2014 · Synced Jul 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00005602 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →